Home / General / New Alzheimer’s Drugs Provide No Meaningful Benefit, Major Evidence Review Concludes

New Alzheimer’s Drugs Provide No Meaningful Benefit, Major Evidence Review Concludes

US News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. Track elected officials, research health conditions, and find news you can use in politics, business, health, and education.

By Dennis Thompson HealthDay ReporterTHURSDAY, April 16, 2026 (HealthDay News) — New anti-amyloid drugs approved to treat Alzheimer’s disease have no clinically meaningful positive effects for patients, a major evidence review has concluded.
Drugs li… [5108 chars]

Source: U.S. News & World Report | Published: 2026-04-16T10:55:00Z

Credit: U.S. News & World Report

Tagged:

Leave a Reply

Your email address will not be published. Required fields are marked *